
Harvard Bioscience Inc
NASDAQ:HBIO

Intrinsic Value
The intrinsic value of one
HBIO
stock under the Base Case scenario is
2.358
USD.
Compared to the current market price of 0.453 USD,
Harvard Bioscience Inc
is
Undervalued by 81%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Harvard Bioscience Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Harvard Bioscience Inc
Balance Sheet Decomposition
Harvard Bioscience Inc
Current Assets | 44.9m |
Cash & Short-Term Investments | 5.5m |
Receivables | 13.5m |
Other Current Assets | 25.9m |
Non-Current Assets | 34.9m |
PP&E | 12.3m |
Intangibles | 19.1m |
Other Non-Current Assets | 3.5m |
Free Cash Flow Analysis
Harvard Bioscience Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Harvard Bioscience Inc
Revenue
|
91.4m
USD
|
Cost of Revenue
|
-39.2m
USD
|
Gross Profit
|
52.2m
USD
|
Operating Expenses
|
-56.9m
USD
|
Operating Income
|
-4.8m
USD
|
Other Expenses
|
-53.3m
USD
|
Net Income
|
-58.1m
USD
|
HBIO Profitability Score
Profitability Due Diligence
Harvard Bioscience Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Score
Harvard Bioscience Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
HBIO Solvency Score
Solvency Due Diligence
Harvard Bioscience Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Score
Harvard Bioscience Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HBIO Price Targets Summary
Harvard Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
HBIO
is 3.06 USD
with a low forecast of 3.03 USD and a high forecast of 3.15 USD.
Dividends
Current shareholder yield for HBIO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HBIO
stock under the Base Case scenario is
2.358
USD.
Compared to the current market price of 0.453 USD,
Harvard Bioscience Inc
is
Undervalued by 81%.